Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
This 2016 study evaluated the pharmacokinetics and bioavailability of nicotinamide riboside (NR), a vitamin B3 derivative, in both mice and humans. In mice, oral NR administration led to significant increases in hepatic NAD⁺ levels, outperforming other NAD⁺ precursors like nicotinic acid and nicotinamide. In a human pilot study, a single
June 26, 2025
No Comments